| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 657.81 | 512.87 | 419.35 | 344.61 |
| Accumulated Depreciation Total | -46.36 | -54.34 | - | -43.24 |
| Cash Equivalents | 26.00 | 17.00 | 24.82 | 56.94 |
| Other Liabilities Total | 7.45 | 7.06 | 7.00 | 6.17 |
| Accrued Expenses | 13.29 | 29.18 | - | 10.48 |
| Common Stock Total | 13.23 | 13.23 | 13.23 | 13.23 |
| Other Current Assets Total | 1.52 | 1.21 | 15.40 | 0.46 |
| Prepaid Expenses | 2.45 | 3.05 | - | 0.08 |
| Total Assets | 657.81 | 512.87 | 419.35 | 344.61 |
| Additional Paid- In Capital | 34.46 | 34.46 | - | 34.46 |
| Cash | 2.70 | 2.72 | - | - |
| Total Equity | 530.53 | 374.85 | 307.60 | 255.77 |
| Long Term Investments | 1.01 | 1.01 | - | 0.38 |
| Retained Earnings( Accumulated Deficit) | 482.84 | 327.16 | 294.37 | 208.08 |
| Total Common Shares Outstanding | 1.65 | 1.65 | 1.65 | 1.65 |
| Property/ Plant/ Equipment Total- Gross | 211.50 | 236.15 | 15.03 | 143.33 |
| Tangible Book Valueper Share Common Eq | 307.01 | 209.70 | 165.79 | 133.68 |
| Total Liabilities | 127.28 | 138.02 | 111.75 | 88.84 |
| Total Debt | 0.00 | 0.00 | 0.01 | 0.94 |
| Short Term Investments | 235.90 | 106.15 | 91.33 | 12.86 |
| Cashand Short Term Investments | 264.60 | 125.87 | 116.15 | 69.80 |
| Total Receivables Net | 101.17 | 64.34 | 37.45 | 45.95 |
| Notes Payable/ Short Term Debt | 0.00 | 0.00 | 0.01 | 0.28 |
| Accounts Receivable- Trade Net | 87.78 | 49.26 | 37.43 | 33.59 |
| Property/ Plant/ Equipment Total- Net | 165.13 | 181.81 | 116.30 | 100.09 |
| Total Current Liabilities | 119.83 | 130.96 | 102.78 | 80.11 |
| Total Inventory | 95.51 | 103.62 | 95.05 | 90.62 |
| Accounts Payable | 79.39 | 71.02 | 64.69 | 45.50 |
| Other Currentliabilities Total | 27.15 | 30.76 | 38.08 | 23.49 |
| Total Long Term Debt | 0.00 | 0.00 | 0.00 | 0.30 |
| Intangibles Net | 22.76 | 28.03 | 33.40 | 34.68 |
| Other Long Term Assets Total | 1.43 | 1.01 | 3.69 | 1.18 |
| Note Receivable- Long Term | 2.23 | 2.92 | 1.91 | 1.37 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 465.25 | 298.09 | 264.05 | 206.91 |
| Current Portof LT Debt/ Capital Leases | - | 0.00 | 0.00 | 0.36 |
| Capital Lease Obligations | - | 0.00 | 0.00 | 0.29 |
| Long Term Debt | - | - | 0.00 | 0.01 |
| Deferred Income Tax | - | - | 1.97 | 2.26 |
RPG Life Sciences Dividend RPG Life Sciences Bonus RPG Life Sciences News RPG Life Sciences AGM RPG Life Sciences Rights RPG Life Sciences Splits RPG Life Sciences Board Meetings RPG Life Sciences Key Metrics RPG Life Sciences Shareholdings RPG Life Sciences Profit Loss RPG Life Sciences Cashflow RPG Life Sciences Q1 Results RPG Life Sciences Q2 Results RPG Life Sciences Q3 Results RPG Life Sciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks